Business
Press Release Jun 16 2022
Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 16-Jun-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 16-Jun-2022 titled Glenmark becomes the First Pharmaceutical Company to launch Indacaterol + Mometasone Fixed-Dose Combination Drug for Asthma in India View Attachment","length":387,"tagName":"div"}]